Send us a Text Message.

PBM reform in Illinois (tiktok video)

• https://x.com/ManOnMounjaro/status/1812833885375332394

FTC on PBM

• https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf
• https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen

FDA and social media (tiktok video)

• https://news.bloomberglaw.com/health-law-and-business/drug-device-online-misinformation-gets-fda-look-after-10-years

Patient weight-loss expectations

• https://www.endocrinepractice.org/article/S1530-891X(24)00564-0/abstract

Wegovy commercial:

• https://www.business2community.com/business-news/ozempic-wegovy-maker-novo-nordisk-spends-record-42-m-to-promote-the-drugs-on-tv-is-it-working-02813548

Support the Show.

MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:

Venmo: OnThePen
Ca$h App: ManOnMounjaro

BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

SOCIAL LINKS
https://www.tiktok.com/@manonthemounjaro
https://twitter.com/ManOnMounjaro
https://instagram.com/manonthemounjaro
https://facebook.com/manonthemounjaro

📲 Contact Me: MounjaroMan@gmail.com

📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.